Rydapt is a prescription drug used to treat adults with a cancer of white blood cells known as acute myeloid leukemia (AML). To buy Rydapt 25mg or to know its price contact 3S Corporation.
Manufacturer : Novartis Pharmaceuticals Corporation
Strengths available : 25 mg
Form : Capsules
Dosage : Usual Adult Dose for Acute Myeloid Leukemia– 50 mg orally twice a day at approximately 12 hour intervals on Days 8 to 21 of each cycle of induction AND on Days 8 to 21 of each cycle of consolidation.
Usual Adult Dose for Systemic Mastocytosis–100 mg orally twice a day at approximately 12 hour intervals. Duration of Therapy: Until disease progression or unacceptable toxicity occurs.
Usual Adult Dose for Leukemia– 100 mg orally twice a day at approximately 12 hour intervals.Duration of Therapy: Until disease progression or unacceptable toxicity occurs.
Storage : Store at 25°C
Is the medicine FDA approved : Yes
Date of Approval : April 28, 2017
Common side effects are black, tarry stools, bloody urine, body aches or pain, chest pain, cough, decreased frequency or amount of urine, dizziness, ear congestion, fever or chills, headache, increased thirst, loss of appetite, loss of voice, lower back or side pain, nasal congestion, nausea, painful or difficult urination, pale skin, runny nose, sneezing, sore throat, swelling of the face, fingers, or lower legs, tightness in the chest, troubled breathing, ulcers, sores, or white spots in the mouth, unusual bleeding or bruising, unusual tiredness or weakness, vomiting, weight gain.
7 blister cards containing 4 capsules each.
3S Corporation is a WHO GDSP approved & licensed Pharmaceutical stockist/wholesaler/distributor/exporter/importer of Rydapt Midostaurin 25 mg based in India - To buy Rydapt Midostaurin 25 mg or know its cost price contact us here.
We supply & sell Rydapt Midostaurin 25 mg for Reference Listed Drugs, Government Tenders, Shortage Lists, Emergency Imports, Name Patient Drugs, Comparator Drug Studies, Un-licensed Importation, clinical trial samples & Bio-Similars.